Update - Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply

The access criteria have been amended to reflect developing clinical experience and knowledge of demand and changes in medicine supply. For the NHS in England, new registrations to the EAMS have now closed and initial stock allocations have been made.


Medicines and Healthcare products Regulatory Agency